The system costs
Legislation states that the pharmaceutical industry is responsible for the cost of setting up the medicines verification system. This includes the costs of the EU Hub, as well as the national repositories. In addition, pharmaceutical companies have had to make investments to upgrade their production lines and data systems to meet the requirements of the legislation.
Wholesalers and pharmacies bear the costs of updating their own data systems as well as the acquisition of any needed equipment such as scanners.
Fimvo and the Finnish medicines verification system (FiMVS) are funded with annual fees from MAH’s.
We apply a flat fee which is based on MAHs, not marketing authorisations. If a company represents more than one MAH, the fee will be charged according to the number of MAHs. If an MAH does not have any data in our system, no fee will be applied.
The fees are defined annually according to the Fimvo budget. For 2025 the annual fee is 4 400 € / MAH. And for 2026 the fee will be 4 300 € / MAH.
How to update your invoicing information?
Please always keep us up to date with your invoicing details. Please see the instructions on updating the Appendix I and II template on Sign up with Fimvo page.
Please find below Fimvo's Vendor Details.